• Gardnerella vaginalis
  • Protein S Activity
  • Culture, Vibrio, Stool
  • MEK1 Mutation Analysis, Melanoma
  • Sweat Chloride Test
  • West Nile Virus (WNV) Molecular Detection, Real-time PCR
  • 11-Dehydro-Thromboxane B2, Urine
  • Homovanillic Acid (HVA), 24 Hour, Urine
  • Haemophilus ducreyi, Molecular Method, PCR
  • Biopsy, Head and Neck
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease)
Medical Test

Turnaround Time
Access to Aspartoacylase (ASPA) Gene Mutation Analysis (Canavan Disease) is restricted.